跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
(R)-23a
首页
药物
(R)-23a
(R)-23a
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF SKIN CANCERS
EP 4233865 A3
申请人: NFLECTION THERAPEUTICS INC
优先权: 2018
CN
EP
3 件公开
Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
US 7321046 B2
申请人: UNIV PITTSBURGH
优先权: 2005
US
3 件公开
ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF BIRTHMARKS
EP 4233834 A3
申请人: NFLECTION THERAPEUTICS INC
优先权: 2018
EP
2 件公开
Method for stereoselective synthesis of bicyclical heterocycles
EP 2289881 A1
申请人: BOEHRINGER INGELHEIM INT
优先权: 2009
EP
NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
EP 4245369 A3
申请人: SAGE THERAPEUTICS INC
优先权: 2011
EP
Microrna-based method for assessing the prognosis of a prostate cancer patient
US 10358681 B2
申请人: EXIQON AS
优先权: 2015
US
Method for manufacturing compound
CN 106986889 A
申请人: DONGWOO FINE CHEM CO LTD
优先权: 2015
CN
药物
反馈